In the present study, we used data from The Cancer Genome Atlas (TCGA) and an mRNA array to confirm that KLF5 expression is a key determinant of survival time in pancreatic cancer patients after surgery as well as a prognostic biomarker in pancreatic cancer. Here, KLF5 is linked to familial pancreatic carcinoma.